Celyad SA Sponsored ADR
(NASDAQ : CYAD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.42%168.900.4%$364.86m
VRXValeant Pharmaceuticals International, Inc.
-0.30%22.0714.1%$216.52m
PRGOPerrigo Co. Plc
-0.08%76.156.7%$103.67m
JAZZJazz Pharmaceuticals Plc
-0.73%166.292.2%$88.32m
PTLAPortola Pharmaceuticals, Inc.
-0.82%41.027.7%$80.58m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.16%152.917.6%$74.65m
SAGESAGE Therapeutics, Inc.
1.47%166.689.6%$73.59m
MNKMallinckrodt Plc
1.91%16.0021.1%$57.18m
SUPNSupernus Pharmaceuticals, Inc.
-3.30%54.256.3%$46.86m
UTHRUnited Therapeutics Corporation
-1.24%104.9514.4%$39.79m
PBHPrestige Brands Holdings, Inc.
-0.12%34.263.8%$39.50m
ICPTIntercept Pharmaceuticals, Inc.
-1.73%71.2021.8%$35.11m
CTLTCatalent Inc
0.85%40.562.6%$32.49m
HZNPHorizon Pharma plc
-0.89%14.987.5%$29.51m
IRWDIronwood Pharmaceuticals, Inc. Class A
-0.69%17.9610.2%$27.94m

Company Profile

Celyad SA is a clinical-stage biopharmaceutical company, which engages in the identification and development of specialized cell-based therapies. Its products include cardiopoiesis platform, immuno-oncology, and medical devices. The company was founded by Michel Lussier and William Wijns on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.